Clinical trials
Phase 3 Influenza, Human trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 4 |
| ModernaTX, Inc. | 3 |
| Hoffmann-La Roche | 2 |
| AstraZeneca | 1 |
| BioCryst Pharmaceuticals | 1 |
| Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| MedImmune LLC | 1 |
| Medicago | 1 |
| Sanofi Pasteur, a Sanofi Company | 1 |
| Seqirus | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Influenza, Human | 17 |
| Orthomyxoviridae Infections | 3 |
| Respiratory Tract Diseases | 3 |
| Respiratory Tract Infections | 3 |
| Virus Diseases | 3 |
| COVID-19 | 2 |
| Infections | 2 |
| Lung Diseases | 2 |
| Community-Acquired Pneumonia | 1 |
| Coronavirus Infections | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.